 |
|
|
| |
Compassionate use of subcutaneously administered
REP 2139-Mg in cirrhotic HBV / HDV co-infection
|
| |
| |
AASLD 2022 Nov 4-8
Marc Bourliere1, Veronique Loustaud-Ratti2, Christiane Stern3, Michel Bazinet4, Souad Ben Ali1, Laurence Lecomte1, Sandrine Francois2, Cecilia de Freitas3, Athenaïs Gerber5, Segolene Brichler5, Emmanuel Gordien5, Andrew Vaillant
1. Service Hepato-Gastro-Enterologie, Hopital Saint-Joseph, Marseille, France, 2. Department Hepatogastroenterology, Centre hospitalier universitaire a Limoges, Limoges, France, 3. Department de Hepatologie, AP-HP Hopital Beaujon, Clichy, France
4. Replicor Inc. Montreal, Canada, 5. Centre national de reference des hepatite B, C et Delta - Laboratoire associe, Hopital Avicenne, Bobigny, France
|
| |
|
|
|
|
|
